The global anti-infectives market size reached US$ 134.7 Billion in 2023. Looking forward, the market is projected to reach US$ 177.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.11% during 2023-2032.
Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.
Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.
2. What is the expected growth rate of the global anti-infectives market during 2024-2032?
3. What are the key factors driving the global anti-infectives market?
4. What has been the impact of COVID-19 on the global anti-infectives market?
5. What is the breakup of the global anti-infectives market based on the type?
6. What is the breakup of the global anti-infectives market based on the route of administration?
7. What is the breakup of the global anti-infectives market based on distribution channel?
8. What are the key regions in the global anti-infectives market?
9. Who are the key players/companies in the global anti-infectives market?
Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.
Anti-infectives Market Trends
The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market.Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global anti-infectives market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on type, route of administration and distribution channel.Breakup by Type:
- Antibacterial
- Antifungal
- Antiviral
Breakup by Route of Administration:
- Topical
- Oral
- Intravenous (IV)
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Speciality Pharmacies
- Online Stores
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.Key Questions Answered in This Report
1. What was the size of the global anti-infectives market in 2023?2. What is the expected growth rate of the global anti-infectives market during 2024-2032?
3. What are the key factors driving the global anti-infectives market?
4. What has been the impact of COVID-19 on the global anti-infectives market?
5. What is the breakup of the global anti-infectives market based on the type?
6. What is the breakup of the global anti-infectives market based on the route of administration?
7. What is the breakup of the global anti-infectives market based on distribution channel?
8. What are the key regions in the global anti-infectives market?
9. Who are the key players/companies in the global anti-infectives market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Anti-infectives Market
6 Market Breakup by Type
7 Market Breakup by Route of Administration
8 Market Breakup by Distribution Channel
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Cipla Health Ltd. (Cipla Limited)
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Limited
- Johnson & Johnson
- Lupin Limited
- Sandoz AG (Novartis AG)
- Sun Pharmaceutical Industries Limited
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 137 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 134.7 Billion |
| Forecasted Market Value ( USD | $ 177.5 Billion |
| Compound Annual Growth Rate | 3.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
